Precipio (PRPO) Competitors $14.52 -0.26 (-1.76%) As of 02:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRPO vs. OPXS, INTT, ODYS, AKYA, OPTX, AATC, DAIO, CLIR, MSAI, and STAIShould you be buying Precipio stock or one of its competitors? The main competitors of Precipio include Optex Systems (OPXS), inTEST (INTT), Odysight.ai (ODYS), Akoya Biosciences (AKYA), Syntec Optics (OPTX), Autoscope Technologies (AATC), Data I/O (DAIO), ClearSign Technologies (CLIR), MultiSensor AI (MSAI), and ScanTech AI Systems (STAI). These companies are all part of the "measuring and control equipment" industry. Precipio vs. Its Competitors Optex Systems inTEST Odysight.ai Akoya Biosciences Syntec Optics Autoscope Technologies Data I/O ClearSign Technologies MultiSensor AI ScanTech AI Systems Optex Systems (NASDAQ:OPXS) and Precipio (NASDAQ:PRPO) are both small-cap measuring and control equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership, analyst recommendations and media sentiment. Which has preferable valuation & earnings, OPXS or PRPO? Optex Systems has higher revenue and earnings than Precipio. Precipio is trading at a lower price-to-earnings ratio than Optex Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOptex Systems$33.99M2.77$3.77M$0.7119.19Precipio$18.53M1.18-$4.29M-$2.07-7.01 Is OPXS or PRPO more profitable? Optex Systems has a net margin of 13.06% compared to Precipio's net margin of -15.45%. Optex Systems' return on equity of 25.10% beat Precipio's return on equity.Company Net Margins Return on Equity Return on Assets Optex Systems13.06% 25.10% 19.04% Precipio -15.45%-25.87%-17.93% Do insiders & institutionals hold more shares of OPXS or PRPO? 19.1% of Optex Systems shares are held by institutional investors. Comparatively, 10.5% of Precipio shares are held by institutional investors. 30.3% of Optex Systems shares are held by company insiders. Comparatively, 16.9% of Precipio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility & risk, OPXS or PRPO? Optex Systems has a beta of 0.33, meaning that its stock price is 67% less volatile than the S&P 500. Comparatively, Precipio has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Does the media refer more to OPXS or PRPO? In the previous week, Precipio had 3 more articles in the media than Optex Systems. MarketBeat recorded 4 mentions for Precipio and 1 mentions for Optex Systems. Optex Systems' average media sentiment score of 1.87 beat Precipio's score of 1.17 indicating that Optex Systems is being referred to more favorably in the media. Company Overall Sentiment Optex Systems Very Positive Precipio Positive SummaryOptex Systems beats Precipio on 11 of the 13 factors compared between the two stocks. Get Precipio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRPO vs. The Competition Export to ExcelMetricPrecipioMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.93M$1.98B$5.56B$9.30BDividend YieldN/AN/A4.23%4.03%P/E Ratio-7.0134.1928.6319.67Price / Sales1.1814.93439.23185.66Price / CashN/A54.7436.0257.93Price / Book1.788.608.185.64Net Income-$4.29M-$62.39M$3.23B$257.73M7 Day Performance-10.37%-1.75%-0.20%0.21%1 Month Performance32.72%10.29%5.43%8.47%1 Year Performance227.03%3.60%26.39%13.93% Precipio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRPOPrecipio0.9164 of 5 stars$14.52-1.8%N/A+218.9%$21.93M$18.53M-7.0160Positive NewsOPXSOptex Systems2.3308 of 5 stars$12.95+13.6%N/A+67.2%$89.48M$33.99M18.2480Positive NewsHigh Trading VolumeINTTinTEST3.7543 of 5 stars$7.12-7.3%$12.00+68.5%-37.7%$88.96M$127.50M30.96320ODYSOdysight.ai1.8985 of 5 stars$4.74-1.3%$10.00+111.0%N/A$77.36M$3.96M-4.6540Gap UpAKYAAkoya Biosciences1.9994 of 5 stars$1.29flat$2.51+94.3%N/A$64.44M$79.96M-1.3390Gap UpOPTXSyntec Optics0.5377 of 5 stars$1.33-0.7%N/A-34.3%$48.80M$29.39M0.003Positive NewsAATCAutoscope Technologies1.9144 of 5 stars$7.60+0.1%N/A+19.9%$41.72M$12.89M8.6440DAIOData I/O1.6071 of 5 stars$3.12-0.3%$5.22+67.3%+14.7%$28.83M$21.85M-10.76100CLIRClearSign Technologies2.4536 of 5 stars$0.53-1.8%$2.00+277.2%-36.8%$27.79M$3.60M-4.4210MSAIMultiSensor AI3.7833 of 5 stars$0.81+15.4%$2.50+207.2%-51.0%$27.21M$6.30M0.0035High Trading VolumeSTAIScanTech AI SystemsN/A$0.74+6.9%N/AN/A$18.95M$540K0.00N/ANews Coverage Related Companies and Tools Related Companies Optex Systems Alternatives inTEST Alternatives Odysight.ai Alternatives Akoya Biosciences Alternatives Syntec Optics Alternatives Autoscope Technologies Alternatives Data I/O Alternatives ClearSign Technologies Alternatives MultiSensor AI Alternatives ScanTech AI Systems Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRPO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precipio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
